Meropenem Labatec i.v. 500 mg

Meropenem Labatec i.v. 500 mg is a medicine authorised by Swissmedic under authorisation number 59463. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 18 December 2009 and the authorisation is valid without a time limit. ATC code J01DH02 places the medicine in the group Antibacterials for systemic use.

Dispensing category A
Authorisation number 59463
ATC J01DH02
Synthetic medicines

Authorisation data
Authorisation number	59463
Name	Meropenem Labatec i.v. 500 mg
Full name	Meropenem Labatec i.v. 500 mg, poudre pour injection ou perfusion
Authorisation holder	Labatec Pharma SA
Medicinal product code	Synthetic medicines
Dispensing category	A · Prescription, not repeatable
ATC code	J01DH02
First authorisation	18 December 2009
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	Meropenem Labatec i.v. 500 mg, poudre pour injection ou perfusion	A	18 December 2009
2	Meropenem Labatec i.v. 1 g, poudre pour injection ou perfusion	A	18 December 2009

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	10 x 500	mg	J01DH02	08.01.25	A
2	10 x 1	g	J01DH02	08.01.25	A

Scroll the table sideways

Medicines in the same ATC group

Meronem 500 mgAuthorisation number 53105 · Pfizer AG · ATC J01DH02A Meropenem Fresenius i.v. 500 mgAuthorisation number 62419 · Fresenius Kabi (Schweiz) AG · ATC J01DH02A Meropenem OrPha 500 mgAuthorisation number 70085 · OrPha Swiss GmbH · ATC J01DH02A

Other medicines from this authorisation holder

Aciclovir LabatecAuthorisation number 60325 · ATC J05AB01A Actonel 30 mgAuthorisation number 55214 · ATC M05BA07B Actonel 35 mgAuthorisation number 69144 · ATC M05BA07B Alendronate Labatec 70 mgAuthorisation number 70488B Amiodarone LabatecAuthorisation number 59528 · ATC C01BD01B Anidulafungin Labatec 100 mgAuthorisation number 67756A Atosiban Labatec 6.75 mg / 0.9 mlAuthorisation number 69185 · ATC G02CX01B Atracurium Labatec 10 mg/mlAuthorisation number 60126 · ATC M03AC04B

Frequently asked questions

Is Meropenem Labatec i.v. 500 mg authorised in Switzerland?

Yes. Meropenem Labatec i.v. 500 mg is authorised by Swissmedic under authorisation number 59463, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Meropenem Labatec i.v. 500 mg have?

Meropenem Labatec i.v. 500 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Meropenem Labatec i.v. 500 mg?

The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.